Novel Immunotherapy Trial for Lymphoma Offers Hope to Patients at Sylvester

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are testing a novel cellular immunotherapy approach to treating patients with diffuse large B-cell... [...]

New Treatment May Reduce Precancerous Polyps in Both Large and Small Intestine in Hereditary Cancer Patients

A new study published in the Journal of the American Medical Association (JAMA), has reported a new prevention treatment for individuals at high risk of developing colon cancer due to the APC (adenomatous... [...]

Ask the Lynch Syndrome Expert: Q&A Now Available!

CancerConnect Presents: Ask the Expert with Dana-Farber Cancer Institute’s Dr. Perez Lynch Syndrome: Get the Facts about this Hereditary Cancer Syndrome Kimberly Perez, MD CancerConnect announces the... [...]

More Evidence that PD-1 Inhibitors Improve Survival in Head and Neck Cancer

Results from a recent large trial indicate that treatment with the immunotherapy agent Opdivo® (nivolumab) nearly doubles the survival rate at one year in patients with advanced head and neck squamous... [...]

Counsyl Announces Major Oncology Expansion to Advance Genetic Screening for Cancer Risk

Counsyl launches oncology business unit, an expanded test to assess risk for inherited forms of cancer, and tools to improve genetic screening rates across the healthcare system Counsyl, a DNA testing... [...]

News Briefing in St. Louis on May 24 Addressing the Impact of ICER’S “Value” Determinations for New Multiple Myeloma Therapies

News Conference Will Be Live Streamed RIGHT HERE at: 11 AM EDT; 10 AM CDT To Register Your Attendance: CLICK HERE In advance of the Institute for Clinical and Economic Research’s (ICER) plan to debate... [...]

Lenvima® Approved for Kidney Cancer

The United States Food and Drug Administration (FDA) has approved Lenvima® (lenvatinib) for the treatment of kidney cancer. The approval is for patients with advanced renal cell carcinoma who have received... [...]


Cancer Survivorship: Managing Hot Flashes

By Barrie Cassileth, MS, PhD Hot flashes are a common side effect of treatment in people with hormone-dependent cancers, such as breast and prostate cancer. Hormone replacement therapy, which may be used... [...]

Genetically Modified Poliovirus Granted “Breakthrough” by FDA for Glioblastoma

The United States Food and Drug Administration (FDA) has granted “breakthrough status” designation for the treatment of glioblastoma containing a genetically modified poliovirus. Glioblastoma is an... [...]

« More News Tips & Features

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS